Friday September 8, 5:00 pm Eastern Time
Press Release
Compugen Announces Exercise of Over-Allotment
TEL AVIV, Israel & JAMESBURG, N.J.--(BUSINESS WIRE)--Sept. 8, 2000-- Compugen Ltd. (Nasdaq: CGEN - news) today announced that the underwriters of its initial public offering have exercised in full their over-allotment option to purchase an additional 750,000 ordinary shares. Compugen's completion of the offering results in the total sale of 5,750,000 shares for net proceeds to the Company of $53.5 million.
The shares are being offered through the underwriters, FleetBoston Robertson Stephens Inc., U.S. Bancorp Piper Jaffray Inc. and Invemed Associates LLC.
Compugen (www.cgen.com) is a pioneer in the field of computational genomics and is developing new approaches to computational proteomics. Compugen combines the disciplines of mathematics and computer science with molecular biology to improve its understanding of genomics and proteomics. Compugen develops products and services that enable life scientists to significantly enhance and accelerate their research efforts in the discovery of drugs, therapeutics, diagnostics and agricultural products. Compugen provides its corporate solutions to pharmaceutical, biotechnology and other life science organizations such as Warner-Lambert Company, Human Genome Sciences, Inc. and the U.S. Patent and Trademark Office. In addition, Compugen provides these products and services to molecular biologists and other life scientists through its LabOnWeb.com Web site. Compugen is also commercializing the genes and proteins that it discovers through its Novel Genomics division.
A registration statement relating to these securities was filed and declared effective by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.
--------------------------------------------------------------------------------
Contact:
Compugen Ltd., Tel Aviv
Nurit Benjamini, 972-3-7658525
Email: nurit@compugen.co.il |
